Division of Endocrinology
The section of Endocrinology and Metabolism was established within the MSU CHM Department of Medicine in 1971; Dr David Rovner serving as the Chief for Endocrinology. In the Division of Endocrinology and Metabolism, our mission is to educate, train and inspire learners, advance knowledge, and provides high quality, compassionate, cost conscious care to patients and their families.
The Division provides teaching in the area of endocrinology and metabolism to medical students, residents, fellows, and allied health professionals. Faculty members teach in lecture format, small group learning sessions, and in one-on-one teaching sessions. Medical students may take Endocrinology as an elective rotation. During this rotation, they spend four weeks with the faculty members in the inpatient and outpatient settings.
Saleh Aldasouqi, MD, FACE, ECNU, received his MBBS (MD) degree from Jordan University School of Medicine in 1984. He completed Internal Medicine residency at Hurley Medical Center (Co-Chief Resident) in Flint, MI (MSU) in 1994, followed by Endocrinology fellowship (Chief Fellow) at Indiana University in Indianapolis, IN, in 1996. After postgraduate training, Dr. Aldasouqi started his endocrine career in 1996 at the Endocrinology Associates Private Practice in Cape Girardeau, MO (as a junior associate of Dr. Daniel Duick, a nationally renowned thyroid expert and co-founder of the American College of Endocrinology’s Neck Ultrasound Educational Program). He has then worked in both private practice and academia, in the Kingdom of Saudi Arabia (KSA) and the USA. Dr. Aldasouqi began his affiliation with MSU in 2004, as a Clinical Assistant Professor (Flint Campus).
Dr. Aldasouqi has been active in teaching, clinical and research, accumulating several scholarly achievements. He has held several administrative and leadership positions at prior and current jobs. He developed or modernized thyroid and diabetes centers during his work in Missouri, Saudi Arabia, and Michigan (Sparrow and MSU). At MSU, in collaboration with Dr. Ved Gossain, Dr. Aldasouqi co-founded the MSU’s Endocrine Fellowship Program, formerly serving as the Fellowship’s Associate Program Director. Dr. Aldasouqi served as the Endocrine Division’s Acting Chief as of 2012, and was assigned as the Division’s Chief in January, 2015.
Ved Gossain, MD, FRCP (c), MACP, FACE is the emeritus (active) Swartz Professor of Medicine and former Chief of the Division of Endocrinology and Metabolism, at Michigan State University (MSU). He has relinquished his administrative responsibilities, but continues to teach, serving his patients and carrying out research. He served as Chief of the Division of Endocrinology from 1996-2015. He established the Endocrinology Fellowship Program at MSU and served as the program director since its inception in 2006 to 2013. Dr. Gossain has an international reputation in the field of Endocrinology. Dr. Gossain has been an active clinical researcher and has published over 80 original papers and several book chapters. He has been elected to Alpha Omega Alpha Honor Society and fellowships of Royal College of Physicians of Canada (FRCP©), American Association of Clinical Endocrinologists, (FACE) and All India Institute of Diabetes. He was awarded Mastership in the American College of Physicians (MACP) in 2014. He has received numerous honors and awards including Presidential Citation (Ingham county 1999), Laureate Award (American College of Physicians Michigan Chapter 2004), Distinguished Faculty Award (College of Human Medicine, MSU 2006), Professor Vishwanathan Oration Award (Research Society for Study of Diabetes in India 2000). Academic Excellence Award (Michigan Association of Physicians of Indian Origin 2009), Distinguished Alumnus Award (Amritsar Medical and Dental Association of North America 2010) He has been listed among the “Best Doctors in America” for the last several years.
Dr. Gossain received his basic medical degree (MBBS) from Medical College Amritsar and subsequently obtained a post-doctoral degree in General Medicine (MD) from All India Institute of Medical Sciences, New Delhi, India. He served an Internal Medicine Residency at the Springfield Hospital Medical Center (now Bay State Medical Center) in Springfield, Massachusetts; an Endocrinology Fellowship at the University of Cincinnati, Ohio; and an additional year of Endocrinology Research Fellowship at the Medical College of Wisconsin in Milwaukee, Wisconsin.
G. Matthew Hebdon M.D., Ph.D. received his Ph.D. from the National Institute for Medical Research in London U.K. for work on the transport of Ca++ through lipid bilayers and the synthesis of lipid-selective photo-activated probes. Following post-Doctoral Research he was appointed Director of Chemotherapy for Glaxo Pharmaceuticals.
Dr. Hebdon received his M.D. from the University of North Carolina at Chapel Hill and completed Residencies in Internal Medicine and Pediatrics and Fellowships in Adult and Pediatric Endocrinology Nutrition and Metabolism at the University of Michigan. Before coming to Michigan State University he was at the University of Maryland. He is the Program Director for the Endocrinology and Metabolism Fellowship at M.S.U.
Dr. Hebdon sees patients with all endocrine problems; his research interests include diabetes and healthcare outcomes.
Navenn Kakumanu, M.D. joined the Department of Medicine on October, 2013. He graduated from Saint George’s University, School of Medicine in Grenada where he received a full academic scholarship as only one of three recipients in his country. He completed his residency in Internal Medicine at the Detroit Medical Center, Wayne State University and was Chief Medical Resident, ambulatory clinic preceptor at Harper/Hutzel University Hospital, Detroit Medical Center. He completed a Geriatric Fellowship at Wayne State University and received the Lavoisier Cardozo Award for Excellence in Geriatric Medicine. Endocrinology fellowship was completed at Henry Ford Hospital in 2013 He is board certified in Internal Medicine, Geriatric Medicine and Endocrinology. He has a publication in the New England Journal of Medicine on skeletal fluorosis due to excessive tea drinking, and has presented multiple posters and abstracts at the Endocrine Society, American Association of Clinical Endocrinologists and American Society for Bone and Mineral Research. His speciality in Endocrinology is diverse with interest in thyroid disorders, diabetes and bone metabolism.
Dr. Kakumanu is a member of Iota Epsilon Alpha and is fluent in Telugu. Hobbies include cricket, teaching, tennis, basketball, reading novels, and interacting with people from all walks of life.
The Division conducts clinical research and participates in basic research in collaboration with basic science faculty. An example is the Global Hypopituitary Control and Complications Study (HypoCCS) which is part of an international collaboration project to evaluate the effects of growth hormone replacement in growth hormone deficient adults. Other studies include an evaluation of a Shared Decision Making model to improve the care of diabetes and a study to evaluate the utility of MRI in the early detection of diabetic microangiopathy. A recently funded study investigated the prevalence of diabetes/cardiovascular risk factors and the effectiveness of risk factor modification among UAW-GM employees. Other important projects deal with the use of glycosylated hemoglobin in gestational diabetes, the effectiveness of insulin pumps in community settings, fatty acid profiles in diabetics, and the natural history of subclinical hyperthyroidism with and without treatment. The outcome of the studies outlined above will advance knowledge, and depending on the results, may result in improved treatment of patients affected by the endocrine disorders.
Endocrinology Contact Information
Clinic Contact Information:
Phone: (517) 353-4830
Fax: (517) 355-2134
804 Service Road, Suite A205C
East Lansing, MI 48824
Academic Contact Information Division Assistant: Jinie Shirey
Phone: (517) 353-3730